Department of Anesthesiology, Laboratory of Anesthesia & CCM, Translational Neuroscience Center, State Key Laboratory of Biotherapy of Cancer, West China Hospital of Sichuan University, Chengdu, Sichuan, People's Republic of China.
Anesthesiology. 2013 Apr;118(4):785-95. doi: 10.1097/ALN.0b013e318287b7c8.
Ketamine is a commonly used anesthetic, but the mechanistic basis for its clinically relevant actions remains to be determined. The authors previously showed that HCN1 channels are inhibited by ketamine and demonstrated that global HCN1 knockout mice are twofold less sensitive to hypnotic actions of ketamine. Although that work identified HCN1 channels as a viable molecular target for ketamine, it did not determine the relevant neural substrate.
To localize the brain region responsible for HCN1-mediated hypnotic actions of ketamine, the authors used a conditional knockout strategy to delete HCN1 channels selectively in excitatory cells of the mouse forebrain. A combination of molecular, immunohistochemical, and cellular electrophysiologic approaches was used to verify conditional HCN1 deletion; a loss-of-righting reflex assay served to ascertain effects of forebrain HCN1 channel ablation on hypnotic actions of ketamine.
In conditional knockout mice, HCN1 channels were selectively deleted in cortex and hippocampus, with expression retained in cerebellum. In cortical pyramidal neurons from forebrain-selective HCN1 knockout mice, effects of ketamine on HCN1-dependent membrane properties were absent; notably, ketamine was unable to evoke membrane hyperpolarization or enhance synaptic inputs. Finally, the EC50 for ketamine-induced loss-of-righting reflex was shifted to significantly higher concentrations (by approximately 31%).
These data indicate that forebrain principal cells represent a relevant neural substrate for HCN1-mediated hypnotic actions of ketamine. The authors suggest that ketamine inhibition of HCN1 shifts cortical neuron electroresponsive properties to contribute to ketamine-induced hypnosis.
氯胺酮是一种常用的麻醉剂,但它在临床上相关作用的机制基础仍有待确定。作者先前表明,氯胺酮抑制 HCN1 通道,并证明全局 HCN1 敲除小鼠对氯胺酮的催眠作用的敏感性降低了两倍。尽管该研究确定 HCN1 通道是氯胺酮的可行分子靶标,但它并未确定相关的神经基质。
为了确定负责氯胺酮介导的 HCN1 催眠作用的脑区,作者使用条件性敲除策略选择性地在小鼠前脑的兴奋性细胞中删除 HCN1 通道。采用分子、免疫组织化学和细胞电生理方法相结合来验证条件性 HCN1 缺失;翻正反射丧失试验用于确定前脑 HCN1 通道消融对氯胺酮催眠作用的影响。
在条件性敲除小鼠中,HCN1 通道选择性地在皮质和海马中被删除,而在小脑中有表达保留。在前脑选择性 HCN1 敲除小鼠的皮质锥体神经元中,氯胺酮对 HCN1 依赖性膜特性的作用消失;值得注意的是,氯胺酮无法引起膜超极化或增强突触输入。最后,氯胺酮诱导的翻正反射丧失的 EC50 向更高的浓度显著转移(约 31%)。
这些数据表明,前脑主要细胞代表了氯胺酮介导的 HCN1 催眠作用的相关神经基质。作者提出,氯胺酮抑制 HCN1 将皮质神经元的电反应特性转移,有助于氯胺酮诱导的催眠作用。